Groupe Berkem Société anonyme (ALKEM.PA)
| Previous Close | 1.9000 |
| Open | 1.8900 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 1.8400 - 2.1900 |
| 52 Week Range | 1.1800 - 6.1000 |
| Volume | |
| Avg. Volume | 12,174 |
| Market Cap | 38.588M |
| Beta (5Y Monthly) | 1.04 |
| PE Ratio (TTM) | 109.00 |
| EPS (TTM) | 0.0200 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Jul 04, 2022 |
| 1y Target Est | 5.20 |
Business WireGroupe Berkem: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
BLANQUEFORT, France, May 03, 2024--Regulatory News: Groupe Berkem (Paris:ALKEM):
Business WireGroupe Berkem Announces Its Full-Year 2023 Financial Results and Its Revenue for the First Quarter of 2024
BLANQUEFORT, France, April 30, 2024--Regulatory News: Groupe Berkem, a leading player in bio-based chemistry (ISIN code: FR00140069V2 – Ticker: ALKEM), announces its full-year financial results for the year ended December 31, 2023, as approved by its Board of Directors on April 26, 2024. The audit procedures on the full-year accounts have been conducted and the auditors' report is being issued. The Company also reports on its 2024 first-quarter revenue.
Business WireGroupe Berkem announces 2023 Full-Year Revenue of €52.4 million
BLANQUEFORT, France, February 06, 2024--Regulatory News: Groupe Berkem, a leading player in bio-based chemistry (ISIN code: FR00140069V2 – Ticker: ALKEM), today announces its consolidated 2023 full-year revenue, as at December 31, 2023.
